Crawford Investment Counsel’s Utah Medical Products UTMD Stock Holding History

Crawford Investment Counsel’s Portfolio UTMD Stock Details UTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-11,766	Closed	-$689K	–	256
2015 Q4	$689K	Sell	11,766 -280	-2%	-$15.9K	0.03%	172
2015 Q3	$649K	Sell	12,046 -1,700	-12%	-$92.7K	0.03%	175
2015 Q2	$820K	Sell	13,746 -784	-5%	-$44.1K	0.03%	161
2015 Q1	$870K	Sell	14,530 -3,149	-18%	-$185K	0.03%	158
2014 Q4	$1.06M	Sell	17,679 -2,301	-12%	-$127K	0.04%	143
2014 Q3	$974K	Hold	19,980	–	–	0.04%	136
2014 Q2	$1.03M	Buy	19,980 +2,400	+14%	+$123K	0.04%	136
2014 Q1	$1.02M	Buy	17,580 +1,200	+7%	+$65.5K	0.04%	128
2013 Q4	$936K	Buy	16,380 +10,740	+190%	+$589K	0.03%	135
2013 Q3	$335K	Buy	+5,640	New	+$308K	0.01%	193

Other funds holding UTMD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MDCM

Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Crawford Investment Counsel's UTMD Position: Q1 2016 in Review

Crawford Investment Counsel sold out of Utah Medical Products (UTMD) in Q1 2016, closing a stake of 11,766 shares — an estimated $689K sold.

Crawford Investment Counsel first reported a position in UTMD in Q3 2013 and held it in 10 quarters. The position peaked at $1.06M in Q4 2014. 68 funds tracked by Wall St. Rank hold UTMD as of Q1 2016.

Crawford Investment Counsel reported no remaining Utah Medical Products position as of Q1 2016 after selling out during the quarter.
Crawford Investment Counsel sold 11,766 Utah Medical Products shares in Q1 2016, an estimated $689K.
Crawford Investment Counsel first reported a position in Utah Medical Products in Q3 2013 and held it in 10 quarters.
Crawford Investment Counsel's Utah Medical Products position peaked at $1.06M in Q4 2014.
68 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2016.

Based on Crawford Investment Counsel's 13F filing for Q1 2016, filed 13 May 2016.